Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Machaon Bonafede

Showing results (21-30 of 91) with videos related to

Pageof 10
Sort By:
Advances in Therapy|August 14, 2012
Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settingsMachaon Bonafede, Kathleen M Fox, Crystal Watson, et al.
Journal of Medical Economics|February 9, 2013
Cost-effectiveness of efavirenz vs rilpivirine in HIV patients initiating first-line combination antiretroviral therapyMachaon Bonafede, Timothy Juday, Greg Lenhart, et al.
BMC Endocrine Disorders|June 27, 2013
Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database studyManjiri Pawaskar, Machaon Bonafede, Barbara Johnson, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 24, 2014
Cost of tumor necrosis factor blockers per patient with rheumatoid arthritis in a multistate Medicaid populationMachaon Bonafede, George J Joseph, Neel Shah, et al.
Current Medical Research and Opinion|March 31, 2016
Analysis of subsequent surgery rates among endometriosis patients who underwent surgery with and without concomitant leuprolide acetate therapyAhmed M Soliman, Machaon Bonafede, Amanda M Farr, et al.
BMC Neurology|June 7, 2022
Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosisRobert J Fox, Rina Mehta, Timothy Pham, et al.
Advances in Therapy|February 17, 2018
Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United StatesAhmed M Soliman, Eric Surrey, Machaon Bonafede, et al.
Journal of Managed Care & Specialty Pharmacy|April 29, 2016
Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back TherapyAhmed M Soliman, Machaon Bonafede, Amanda M Farr, et al.
The Journal of Dermatological Treatment|February 28, 2013
Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world settingMachaon Bonafede, Barbara H Johnson, Kathleen M Fox, et al.
Expert Opinion on Drug Safety|January 6, 2015
Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilarsGustavo Grampp, Machaon Bonafede, Thomas Felix, et al.
Pageof 10

Showing results (21-30 of 91) with videos related to

Sort By:
Pageof 10
Advances in Therapy|August 14, 2012
Treatment patterns in the first year after initiating tumor necrosis factor blockers in real-world settingsMachaon Bonafede, Kathleen M Fox, Crystal Watson, et al.
Journal of Medical Economics|February 9, 2013
Cost-effectiveness of efavirenz vs rilpivirine in HIV patients initiating first-line combination antiretroviral therapyMachaon Bonafede, Timothy Juday, Greg Lenhart, et al.
BMC Endocrine Disorders|June 27, 2013
Medication utilization patterns among type 2 diabetes patients initiating Exenatide BID or insulin glargine: a retrospective database studyManjiri Pawaskar, Machaon Bonafede, Barbara Johnson, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 24, 2014
Cost of tumor necrosis factor blockers per patient with rheumatoid arthritis in a multistate Medicaid populationMachaon Bonafede, George J Joseph, Neel Shah, et al.
Current Medical Research and Opinion|March 31, 2016
Analysis of subsequent surgery rates among endometriosis patients who underwent surgery with and without concomitant leuprolide acetate therapyAhmed M Soliman, Machaon Bonafede, Amanda M Farr, et al.
BMC Neurology|June 7, 2022
Real-world disease-modifying therapy pathways from administrative claims data in patients with multiple sclerosisRobert J Fox, Rina Mehta, Timothy Pham, et al.
Advances in Therapy|February 17, 2018
Real-World Evaluation of Direct and Indirect Economic Burden Among Endometriosis Patients in the United StatesAhmed M Soliman, Eric Surrey, Machaon Bonafede, et al.
Journal of Managed Care & Specialty Pharmacy|April 29, 2016
Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back TherapyAhmed M Soliman, Machaon Bonafede, Amanda M Farr, et al.
The Journal of Dermatological Treatment|February 28, 2013
Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world settingMachaon Bonafede, Barbara H Johnson, Kathleen M Fox, et al.
Expert Opinion on Drug Safety|January 6, 2015
Active and passive surveillance of enoxaparin generics: a case study relevant to biosimilarsGustavo Grampp, Machaon Bonafede, Thomas Felix, et al.
Pageof 10